SinoPep: difference between revisions
Diff·revision 1 → 2·03:33, 18 Jun 2025
Difference between revision 1 and revision 2 of SinoPep. 6 lines changed; the page grew by 998 bytes.
| Revision 1 — 23:12, 17 Jun 2025 BlindSampleBrid (talk) new article: supplier organisation, created after the notability discussion 1,941 bytes +1,941 | Revision 2 — 03:33, 18 Jun 2025 Ref_Desk_Ron (talk) state the city and province of the registered address 2,939 bytes +998 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | == Corporate identity and history == | |
| + | 13 | Incorporated in Changzhou in 2011, the organisation sits in the middle of the incorporation dates among the entities covered on this wiki and predates the current research-peptide trade by several years.{{r|registry}} | |
| + | 14 | ||
| + | 15 | The organisation describes itself as performing its own Fmoc solid-phase synthesis rather than finishing material made elsewhere. That is a self-published characterisation and is recorded here as one, not adopted.{{r|selfpub}} What the submitted set does establish is narrower: technical questions about resin selection and purification steps have been answered directly rather than referred onward, which is consistent with the characterisation without confirming it.{{r|reports}} | |
| + | 16 | ||
| 12 | == References == | 17 | == References == |
| 13 | {{reflist}} | 18 | {{reflist}} |
| 14 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> | 19 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> |
| 15 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> | 20 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> |
| + | 21 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | |
| 16 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 22 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 17 | 23 |